Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
Open Access
- 12 August 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (8) , 762
Abstract
Many patients require multi-drug combinations, and adverse event profiles reflect not only the effects of individual drugs but also drug–drug interactions. Although there are several algorithms for detecting drug–drug interaction signals, a simple analysis model is required for early detection of adverse events. Recently, there have been reports of detecting signals of drug–drug interactions using subset analysis, but appropriate detection criterion may not have been used. In this study, we presented and verified an appropriate criterion. The data source used was the Japanese Adverse Drug Event Report (JADER) database; “hypothetical” true data were generated through a combination of signals detected by three detection algorithms. The accuracy of the signal detection of the analytic model under investigation was verified using indicators used in machine learning. The newly proposed subset analysis confirmed that the signal detection was improved, compared with signal detection in the previous subset analysis, on the basis of the indicators of Accuracy (0.584 to 0.809), Precision (= Positive predictive value; PPV) (0.302 to 0.596), Specificity (0.583 to 0.878), Youden’s index (0.170 to 0.465), F-measure (0.399 to 0.592), and Negative predictive value (NPV) (0.821 to 0.874). The previous subset analysis detected many false drug–drug interaction signals. Although the newly proposed subset analysis provides slightly lower detection accuracy for drug–drug interaction signals compared to signals compared to the Ω shrinkage measure model, the criteria used in the newly subset analysis significantly reduced the amount of falsely detected signals found in the previous subset analysis.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K20731)
This publication has 22 references indexed in Scilit:
- Review of Statistical Methodologies for Detecting Drug–Drug Interactions Using Spontaneous Reporting SystemsFrontiers in Pharmacology, 2019
- A New Search Method Using Association Rule Mining for Drug-Drug Interaction Based on Spontaneous Report SystemFrontiers in Pharmacology, 2018
- Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social mediaBriefings in Bioinformatics, 2017
- Mining clinical text for signals of adverse drug-drug interactionsJournal of the American Medical Informatics Association, 2014
- Signal Detection and Monitoring Based on Longitudinal Healthcare DataPharmaceutics, 2012
- Adverse Event Detection in Drug Development: Recommendations and Obligations Beyond Phase 3American Journal of Public Health, 2008
- The reporting odds ratio and its advantages over the proportional reporting ratioPharmacoepidemiology and Drug Safety, 2004
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting SystemThe American Statistician, 1999
- A Bayesian neural network method for adverse drug reaction signal generationEuropean Journal of Clinical Pharmacology, 1998